We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




How Ibogaine Reverses Alcohol Addiction

By Biotechdaily staff writers
Posted on 03 Feb 2005
Researchers using rodent models have found that the controversial drug ibogaine reverses alcohol addiction by increasing the level of the protein GDNF (glial cell line-derived neurotrophic factor) in the ventral tegmental area of the brain. More...


Ibogaine, which is extracted from a West African shrub, has been shown to reverse addiction to alcohol and some drugs, but potentially serious side effects have prevented its widespread acceptance.

In a paper published in the January 19, 2005, issue of The Journal of Neuroscience, investigators at the University of California (San Francisco, USA) showed that ibogaine acted specifically on the ventral tegmental area of the brain. After injecting the drug into the brains of rats, the investigators found that loss of craving for alcohol was accompanied by an increase in the level of GDNF expressed by cells in the ventral tegmental area. Treating the animals with specific antibodies to prevent GDNF expression reversed the anti-addictive action of ibogaine, and direct injection of GDNF prevented addiction in the same manner as injection of ibogaine.

"By identifying the brain protein that ibogaine regulates to reduce alcohol consumption in rats, we have established a link between GDNF and reversal of addiction--knowledge of a molecular mechanism that should allow development of a new class of drugs to treat addiction without ibogaine's side effects,” said senior author Dr. Dorit Ron, associate professor of neurology at the University of California, San Francisco. "If we can alter the GDNF pathway, we may well have a new treatment against alcohol and drug addiction without the unwanted side effects of ibogaine.”



Related Links:
University of California, San Francisco

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.